Related references
Note: Only part of the references are listed.The Effects of 17 beta-estradiol on Mitochondrial Biogenesis and Function in Breast Cancer Cell Lines are Dependent on the ER alpha/ER beta Ratio
Jorge Sastre-Serra et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2012)
CIITA is silenced by epigenetic mechanisms that prevent the recruitment of transactivating factors in rhabdomyosarcoma cells
Priya Londhe et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Optimal MHC-II-restricted tumor antigen presentation to CD4+T helper cells: the key issue for development of anti-tumor vaccines
Roberto S. Accolla et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
Comparison of Functional Proteomic Analyses of Human Breast Cancer Cell Lines T47D and MCF7
Juliette Adjo Aka et al.
PLOS ONE (2012)
Dysregulated Recruitment of the Histone Methyltransferase EZH2 to the Class II Transactivator (CIITA) Promoter IV in Breast Cancer Cells
Agnieszka D. Truax et al.
PLOS ONE (2012)
Estradiol receptors in breast cancer cells: Associated co-factors as targets for new therapeutic approaches
Jack-Michel Renoir
STEROIDS (2012)
STAT1-deficient mice spontaneously develop estrogen receptor α-positive luminal mammary carcinomas
Szeman Ruby Chan et al.
BREAST CANCER RESEARCH (2012)
A Novel Role for IFN-Stimulated Gene Factor 3II in IFN-γ Signaling and Induction of Antiviral Activity in Human Cells
Angel N. Morrow et al.
JOURNAL OF IMMUNOLOGY (2011)
The Role of Interferon Regulatory Factor-1 (IRF1) in Overcoming Antiestrogen Resistance in the Treatment of Breast Cancer
J. L. Schwartz et al.
INTERNATIONAL JOURNAL OF BREAST CANCER (2011)
Loss of interferon regulatory factor 5 (IRF5) expression in human ductal carcinoma correlates with disease stage and contributes to metastasis
Xiaohui Bi et al.
BREAST CANCER RESEARCH (2011)
New Strategies of Mammary Cancer Vaccination
Roberto S. Accolla et al.
BREAST JOURNAL (2010)
Effects of infiltrating lymphocytes and estrogen receptor on gene expression and prognosis in breast cancer
Alberto Calabro et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Inhibition of histone deacetylase suppresses EGF signaling pathways by destabilizing EGFR mRNA in ER-negative human breast cancer cells
Qun Zhou et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Epigenetics meets estrogen receptor: regulation of estrogen receptor by direct lysine methylation
Qun Zhou et al.
ENDOCRINE-RELATED CANCER (2009)
Roles of phosphatidylinositol 3-kinase and p38 mitogen-activated protein kinase in the regulation of protein kinase C-α activation in interferon-γ-stimulated macrophages
Pierre-Olivier Hardy et al.
IMMUNOLOGY (2009)
Recruitment of Stat1 to chromatin is required for interferon-induced serine phosphorylation of Stat1 transactivation domain
Iwona Sadzak et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
EGFR induces expression of IRF-1 via STAT1 and STAT3 activation leading to growth arrest of human cancer cells
Peter Andersen et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Persistent use of false cell lines
Marc Lacroix
INTERNATIONAL JOURNAL OF CANCER (2008)
Reversal of the estrogen receptor-negative phenotype in breast cancer and restoration of antiestrogen response
Jill Bayliss et al.
CLINICAL CANCER RESEARCH (2007)
Membrane-associated estrogen receptor signaling pathways in human cancers
Richard J. Pietras et al.
CLINICAL CANCER RESEARCH (2007)
MDA-MB-435 cells are derived from M14 melanoma cells - a loss for breast cancer, but a boon for melanoma research
James M. Rae et al.
BREAST CANCER RESEARCH AND TREATMENT (2007)
Estrogen receptors:: How do they signal and what are their targets
Nina Heldring et al.
PHYSIOLOGICAL REVIEWS (2007)
Estrogen receptor β2 negatively regulates the transactivation of estrogen receptor α in human breast cancer cells
Chunyan Zhao et al.
CANCER RESEARCH (2007)
A novel c-Jun-dependent signal transduction pathway necessary for the transcriptional activation of interferon γ response genes
Daniel J. Gough et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Pathologic expression of MHC class II is driven by mitogen-activated protein kinases
Isabelle Martins et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
Estrogen signaling multiple pathways to impact gene transcription
Maria Marino et al.
CURRENT GENOMICS (2006)
Epigenetic silencing of MHC2TA transcription in cancer
Tjadine M. Holling et al.
BIOCHEMICAL PHARMACOLOGY (2006)
Tumor cell expression of HLA-DM associates with a Th1 profile and predicts improved survival in breast carcinoma patients
Sharon A. Oldford et al.
INTERNATIONAL IMMUNOLOGY (2006)
IFN-γ and its receptor subunit IFNGR1 are recruited to the IFN-γ-activated sequence element at the promoter-site of IFN-γ-activated genes:: Evidence of transactivational activity in IFNGR1
CMI Ahmed et al.
JOURNAL OF IMMUNOLOGY (2006)
ERα and ERβ expression and transcriptional activity are differentially regulated by HDAC inhibitors
V Duong et al.
ONCOGENE (2006)
Epigenetic regulation of MHC-II and CIITA genes
Kenneth L. Wright et al.
TRENDS IN IMMUNOLOGY (2006)
Differential expression of MHC class II molecules in highly metastatic breast cancer cells is mediated by the regulation of the CIITA transcription - Implication of CIITA in tumor and metastasis development
B Shi et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2006)
The PI3′ kinase pathway in interferon signaling
S Kaur et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2005)
Interplay among coactivator-associated arginine methyltransferase 1, CBP, and CIITA in IFN-γ-inducible MHC-II gene expression
E Zika et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
17 beta-estradiol activation of the c-Jun N-terminal kinase pathway leads to down-regulation of class II major histocompatibility complex expression
J Adamski et al.
MOLECULAR ENDOCRINOLOGY (2005)
17 beta-estradiol-dependent activation of signal transducer and activator of transcription-1 in human fetal osteoblasts is dependent on Src kinase activity
AM Kennedy et al.
ENDOCRINOLOGY (2005)
The histone deacetylase inhibitor trichostatin A sensitizes estrogen receptor α-negative breast cancer cells to tamoxifen
ER Jang et al.
ONCOGENE (2004)
The S box of major histocompatibility complex class II promoters is a key determinant for recruitment of the transcriptional co-activator CIITA
A Muhlethaler-Mottet et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
17β-estradiol inhibits class II major histocompatibility complex (MHC) expression:: Influence on histone modifications and CBP recruitment to the class II MHC promoter
J Adamski et al.
MOLECULAR ENDOCRINOLOGY (2004)
Cutting edge:: Induction of the antigen-processing enzyme IFN-γ-inducible lysosomal thiol reductase in melanoma cells is STAT1-dependent but CUTA-independent
PW O'Donnell et al.
JOURNAL OF IMMUNOLOGY (2004)
Discordant expression of HLA class II-associated co-chaperones and HLA-DRB alleles in cultured fibroblast-like synoviocytes
DR Spurrell et al.
HUMAN IMMUNOLOGY (2004)
HLA-DRB alleles are differentially expressed by tumor cells in breast carcinoma
SA Oldford et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Importance of class II transactivator leucine-rich repeats for dominant-negative function and nucleo-cytoplasmic transport
MM Camacho-Carvajal et al.
INTERNATIONAL IMMUNOLOGY (2004)
IFN-γ-Induced MHC class II expression:: Transactivation of class II transactivator promoter IV by IFN regulatory factor-1 is regulated by protein kinase C-α
M Giroux et al.
JOURNAL OF IMMUNOLOGY (2003)
Stable transfection of an estrogen receptor beta cDNA isoform into MDA-MB-231 breast cancer cells
DA Tonetti et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2003)
Sources of estrogen and their importance
ER Simpson
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2003)
Comparison of the transcriptional regulation of classical and non-classical MHC class II genes
SB Hake et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)
Histone deacetylation, but not hypermethylation, modifies class II transactivator and MHC class II gene expression in squamous cell carcinomas
T Kanaseki et al.
JOURNAL OF IMMUNOLOGY (2003)
Tumor rejection by gene transfer of the MHC class II transactivator in murine mammary adenocarcinoma cells
R Meazza et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)
Bidirectional signaling between the estrogen receptor and the epidermal growth factor receptor
ER Levin
MOLECULAR ENDOCRINOLOGY (2003)
Steroid receptor coactivator 1 links the steroid and interferon gamma response pathways
E Tzortzakaki et al.
MOLECULAR ENDOCRINOLOGY (2003)
Transcriptional regulation of the MHC class II trans-activator (CIITA) promoter III:: Identification of a novel regulatory region in the 5′-untranslated region and an important role for cAMP-responsive element binding protein 1 and activating transcription factor-1 in CIITA-promoter III transcriptional activation in B lymphocytes
N van der Stoep et al.
JOURNAL OF IMMUNOLOGY (2002)
p38 MAPK enhances STAT1-dependent transcription independently of Ser-727 phosphorylation
K Ramsauer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Kinetics of a gamma interferon response: Expression and assembly of CIITA promoter IV and inhibition by methylation
AC Morris et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Signaling through the JAK/STAT pathway, recent advances and future challenges
T Kisseleva et al.
GENE (2002)
Epidermal growth factor receptor (EGFR) transactivation by estrogen via the G-protein-coupled receptor, GPR30: a novel signaling pathway with potential significance for breast cancer
EJ Filardo
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2002)
Expression of HLA class II in colorectal cancer: Evidence for enhanced immunogenicity of microsatellite-instability-positive tumours
SA Bustin et al.
TUMOR BIOLOGY (2001)
Transcriptional scaffold: CIITA interacts with NF-Y, RFX, and CREB to cause stereospecific regulation of the class II major histocompatibility complex promoter
XS Zhu et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Loss of MHC class II expression is associated with a decrease of tumor-infiltrating T cells and an increase of metastatic potential of colorectal cancer: Immunohistological and histopathological analyses as compared with normal colonic mucosa and adenomas
M Warabi et al.
PATHOLOGY RESEARCH AND PRACTICE (2000)
Share Paper
